GVK eyes biologicals space with Aragen acquisition
This article was originally published in Scrip
Executive Summary
India's GVK Biosciences is acquiring Aragen Bioscience, a privately held US preclinical contract research organization (CRO) that specializes in high-value biologics services, a move that will expand GVK's service offerings beyond small-molecule platforms.